Table 1 Clinical characteristics of the participants.

From: CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes

 

CF control participants

N = 53

CFRD participants

N = 41

p

Age years, median (IQR)

30 (25–37)

33 (30–41)

0.05

Men n (%)

28 (53)

21 (51)

1

BMIa kg/m2: mean (SD)

21.7 (2.9)

21.1 (3.1)

0.35

Exocrine pancreatic insufficiency n (%)

35 (66)

41 (100)

 < 0.0001

Two severe CFTR mutations n (%)

38 (72)

39 (95)

0.003

Blood tests (until 2016)

 Highest known HbA1ca%: median (IQR)

5.7 (5.4–5.9)

7.5 (6.9–8.5)

 < 0.0001

 Highest known HbA1cammol/mol: median (IQR)

39 (36–41)

58 (52–68)

 

 Highest known fasting glycemiab mmol/L: median (IQR)

5.1 (4.6–5.4)

7.7 (6.2–10.6)

 < 0.0001

  1. CF control participants participants with cystic fibrosis but without diabetes, CFRD participants cystic fibrosis related diabetes, IQR interquartile range, BMI body mass index, SD standard deviation.
  2. aAvailable in 45 control and 38 diabetes participants.
  3. bAvailable in 49 control and 39 diabetes participants.
Back to article page